MedPath

Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing

Not Applicable
Recruiting
Conditions
Cleft Lip and Palate
Interventions
Genetic: identification of genetic factors
Registration Number
NCT03065686
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Despite significant progress made in identification on numerous genes and gene pathways critical for craniofacial development, several approaches, ie mutation screening of specific candidates, association studies and even genome-wide scans have largely failed to reveal the molecular basis of NS human clefting

Detailed Description

Despite significant progress made in identification on numerous genes and gene pathways critical for craniofacial development, several approaches, ie mutation screening of specific candidates, association studies and even genome-wide scans have largely failed to reveal the molecular basis of NS human clefting. Moreover, the efficiency of Whole Exome Sequencing -WES- was proven. The efficiency of WES was proven by the identification of the genes causing Freeman Sheldon and Miller's syndrome, followed by several others. In the Picardy region, management and follow-up of orofacial cleft patients are well-organised by a multidisciplinary team in the university hospital of Amiens. The investigators therefore decided to perform whole exome sequencing (WES) on precisely phenotyped non-syndromic CL/P patients followed in our center.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Subject with a NSCL/P or CL/P of unknown etiology,
  • national health care insurance holders
Exclusion Criteria
  • Subject with a CL/P of known etiology,
  • Subject with a NSCL/P and an IRF6 mutation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Identification of genetic factorsidentification of genetic factorsClinical questionnaire and analysis of genetic data obtained by exome high-throughput sequencing
Primary Outcome Measures
NameTimeMethod
Identification of genetic factorsDay 1

Identification of genetic factors implicated in orofacial cleft using whole exome sequencing (WES).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Amiens Picardie

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath